Bloomberg Law
Jan. 23, 2020, 6:35 PMUpdated: Jan. 23, 2020, 7:06 PM

Gilead Assesses Ebola Drug as Possible Coronavirus Treatment (1)

Jeannie Baumann
Jeannie Baumann

Gilead Sciences Inc. will see whether an experimental Ebola treatment can combat infections of the new SARS-like coronavirus that sprung out of central China in the last month.

The Foster City, Calif.-based biotechnology company “is in active discussions with researchers and clinicians in the United States and China regarding the ongoing Wuhan coronavirus outbreak and the potential use of remdesivir as an investigational treatment,” the company confirmed in a Thursday email to Bloomberg Law. “Plans for next steps, including engagement with regulatory authorities, are ongoing.”

Remdesivir is an experimental antiviral drug that grew out of a collaboration with the Centers ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.